INS and metabolic syndrome: LPCs have been considered as early biomarkers for the development of type 2 diabetes.50 In this study, the baseline levels of the LPC cluster (LC11) also were inversely associated with the 2-month change in the insulin level among lean subjects, indicating their potential as early predictors of metabolic syndrome.